Trial Profile
A Multicenter, Double-Blind, Placebo Controlled,Randomized, Parallel-Group Study to Evaluate the Clinical Effect of Oral Montelukast Versus Placebo in Persistent Asthma Which is Also Active During Allergy Seasons in Pediatric Patients With Seasonal Aeroallergen Sensitivity
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- Sponsors Merck & Co; Organon
- 12 Feb 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 11 Oct 2007 Status changed from recruiting to in progress.
- 02 Feb 2007 New trial centre added.